|Articles|January 1, 2002

January 2002
Volume 8
Issue 1

Postmenopausal Hormone Replacement Therapy and Major Clinical Outcomes: A Focus on Cardiovascular Disease, Osteoporosis, Dementia, and Breast and Endometrial Neoplasia

Author(s)Sarah E. Dick, MD, Dawn E. DeWitt, MD, Bradley D. Anawalt, MD

Download PDF: Postmenopausal Hormone Replacement Therapy and Major Clinical Outcomes: A Focus on Cardiovascular Disease, Osteoporosis, Dementia, and Breast and Endometrial Neoplasia

Articles in this issue

over 24 years ago

Article

TennCare - Medicaid Managed Care in Tennessee in Jeopardy

over 24 years ago

Article

Effects of Restrictive Formularies in the Ambulatory Care Setting

over 24 years ago

Article

The Generalist's Patient and the Subspecialist

over 24 years ago

Article

Can Guidelines Impact the Ordering of Magnetic Resonance Imaging Studies by Primary Care Providers for Low Back Pain?

over 24 years ago

Article

Accuracy of Computerized Outpatient Diagnoses in a Veterans Affairs General Medicine Clinic

over 24 years ago

Article

Issues in Pooling Administrative Data for Economic Evaluation

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Postmenopausal Hormone Replacement Therapy and Major Clinical Outcomes: A Focus on Cardiovascular Disease, Osteoporosis, Dementia, and Breast and Endometrial Neoplasia

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

5 Things to Know About the FDA's Peptide Reversal

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

Contributor: The Deadly Gap in the Charity Care System